Acute Illness Associated With Cannabis Use, by Route of Exposure: An Observational Study
- PMID: 30909297
- PMCID: PMC6788289
- DOI: 10.7326/M18-2809
Acute Illness Associated With Cannabis Use, by Route of Exposure: An Observational Study
Abstract
Background: Little is known about the relative harms of edible and inhalable cannabis products.
Objective: To describe and compare adult emergency department (ED) visits related to edible and inhaled cannabis exposure.
Design: Chart review of ED visits between 1 January 2012 and 31 December 2016.
Setting: A large urban academic hospital in Colorado.
Participants: Adults with ED visits with a cannabis-related International Classification of Diseases, Ninth or 10th Revision, Clinical Modification (ICD-9-CM or ICD-10-CM), code.
Measurements: Patient demographic characteristics, route of exposure, dose, symptoms, length of stay, disposition, discharge diagnoses, and attribution of visit to cannabis.
Results: There were 9973 visits with an ICD-9-CM or ICD-10-CM code for cannabis use. Of these, 2567 (25.7%) visits were at least partially attributable to cannabis, and 238 of those (9.3%) were related to edible cannabis. Visits attributable to inhaled cannabis were more likely to be for cannabinoid hyperemesis syndrome (18.0% vs. 8.4%), and visits attributable to edible cannabis were more likely to be due to acute psychiatric symptoms (18.0% vs. 10.9%), intoxication (48% vs. 28%), and cardiovascular symptoms (8.0% vs. 3.1%). Edible products accounted for 10.7% of cannabis-attributable visits between 2014 and 2016 but represented only 0.32% of total cannabis sales in Colorado (in kilograms of tetrahydrocannabinol) during that period.
Limitation: Retrospective study design, single academic center, self-reported exposure data, and limited availability of dose data.
Conclusion: Visits attributable to inhaled cannabis are more frequent than those attributable to edible cannabis, although the latter is associated with more acute psychiatric visits and more ED visits than expected.
Primary funding source: Colorado Department of Public Health and Environment.
Figures
Comment in
-
Emergency Department Visits From Edible Versus Inhalable Cannabis.Ann Intern Med. 2019 Apr 16;170(8):569-570. doi: 10.7326/M19-0542. Epub 2019 Mar 26. Ann Intern Med. 2019. PMID: 30909298 No abstract available.
Similar articles
-
Why do patients come to the emergency department after using cannabis?Clin Toxicol (Phila). 2020 Jun;58(6):453-459. doi: 10.1080/15563650.2019.1657582. Epub 2019 Sep 16. Clin Toxicol (Phila). 2020. PMID: 31526057 Free PMC article.
-
Mental Health-related Emergency Department Visits Associated With Cannabis in Colorado.Acad Emerg Med. 2018 May;25(5):526-537. doi: 10.1111/acem.13393. Epub 2018 Apr 10. Acad Emerg Med. 2018. PMID: 29476688 Free PMC article.
-
Syndromic Surveillance of Emergency Department Visits for Acute Adverse Effects of Marijuana, Tri-County Health Department, Colorado, 2016-2017.Public Health Rep. 2019 Mar/Apr;134(2):132-140. doi: 10.1177/0033354919826562. Epub 2019 Feb 5. Public Health Rep. 2019. PMID: 30721641 Free PMC article.
-
Cannabis-related emergencies in children and teens.Curr Opin Pediatr. 2019 Jun;31(3):291-296. doi: 10.1097/MOP.0000000000000752. Curr Opin Pediatr. 2019. PMID: 31090567 Review.
-
Cannabis use and the risk of later schizophrenia: a review.Addiction. 2004 Apr;99(4):425-30. doi: 10.1111/j.1360-0443.2004.00683.x. Addiction. 2004. PMID: 15049742 Review.
Cited by
-
Cannabis Use Variations and Myocardial Infarction: A Systematic Review.J Clin Med. 2024 Sep 22;13(18):5620. doi: 10.3390/jcm13185620. J Clin Med. 2024. PMID: 39337107 Free PMC article. Review.
-
Cannabis Use and Inhalational Anesthesia Administration in Older Adults: A Propensity-matched Retrospective Cohort Study.Anesthesiology. 2024 Nov 1;141(5):870-880. doi: 10.1097/ALN.0000000000005146. Anesthesiology. 2024. PMID: 38980341
-
Global epidemiology of cannabis use disorders and its trend from 1990 to 2019: Benchmarking analysis of the global burden of disease study.J Family Med Prim Care. 2024 Mar;13(3):881-889. doi: 10.4103/jfmpc.jfmpc_824_23. Epub 2024 Apr 4. J Family Med Prim Care. 2024. PMID: 38736814 Free PMC article.
-
Cannabis use and cannabis use disorders and their treatment in the Europe.Eur Arch Psychiatry Clin Neurosci. 2024 Mar 15. doi: 10.1007/s00406-024-01776-1. Online ahead of print. Eur Arch Psychiatry Clin Neurosci. 2024. PMID: 38489067
-
Thoughtfully Integrating Cannabis Products Into Chronic Pain Treatment.Anesth Analg. 2024 Jan 1;138(1):5-15. doi: 10.1213/ANE.0000000000005904. Epub 2023 Dec 15. Anesth Analg. 2024. PMID: 38100797 Review.
References
-
- Ogden DW. Investigations and Prosecutions in States Authorizing the Medical Use of Marijuana [Memorandum]. Accessed at http://blogs.justice.gov/main/archives/192 on 18 August 2014.
-
- Colo. Const. amend. LXIV.
-
- Colorado Department of Revenue. Marijuana Sales Reports. Denver: Colorado Department of Revenue; 2018. Accessed at www.colorado.gov/pacific/revenue/colorado-marijuana-sales-reports on 9 July 2018.
-
- Colorado Department of Public Health and Environment. Behavioral Risk Factor Surveillance System and Child Health Survey. Denver: Colorado Department of Public Health and Environment; 2018. Accessed at www.colorado.gov/pacific/cdphe/behaviorsurvey on 7 February 2019.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources